Literature DB >> 2839711

Poliovirus mutant that contains a cold-sensitive defect in viral RNA synthesis.

H D Berstein1, D Baltimore.   

Abstract

By manipulating an infectious cDNA clone of poliovirus, we have introduced a single-codon insertion into the 3A region of the viral genome which has been proposed to encode a functional precursor of the virion-linked protein VPg. The resulting mutant was cold sensitive in monkey kidney cells. Viral RNA synthesis was poor at 32.5 degrees C, although no other function of the virus was obviously affected. The synthesis of both positive and negative strands was severely depressed. Temperature shift experiments suggest that a normal level of production of the affected function was required only during the early (exponential) phase of RNA synthesis. Analysis of viral polyprotein processing at the nonpermissive temperature revealed that some of the normal cleavages were not made, most likely as a consequence of the defect in RNA synthesis or as a result of the concomitant reduction in the level of virally encoded proteases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839711      PMCID: PMC253730          DOI: 10.1128/JVI.62.8.2922-2928.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome.

Authors:  P Sarnow; H D Bernstein; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

2.  Genetic complementation among poliovirus mutants derived from an infectious cDNA clone.

Authors:  H D Bernstein; P Sarnow; D Baltimore
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide.

Authors:  B L Semler; C W Anderson; R Hanecak; L F Dorner; E Wimmer
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

4.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

5.  Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus.

Authors:  T Takegami; R J Kuhn; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Poliovirus mutant that does not selectively inhibit host cell protein synthesis.

Authors:  H D Bernstein; N Sonenberg; D Baltimore
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

7.  Genome-linked protein VPg of poliovirus is present as free VPg and VPg-pUpU in poliovirus-infected cells.

Authors:  N M Crawford; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  In vitro copying of viral positive strand RNA by poliovirus replicase. Characterization of the reaction and its products.

Authors:  M H Baron; D Baltimore
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

9.  Formation of a covalent complex between the 80,000-dalton adenovirus terminal protein and 5'-dCMP in vitro.

Authors:  J H Lichy; M S Horwitz; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides.

Authors:  T Takegami; B L Semler; C W Anderson; E Wimmer
Journal:  Virology       Date:  1983-07-15       Impact factor: 3.616

View more
  28 in total

1.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  cis-acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication.

Authors:  C Giachetti; S S Hwang; B L Semler
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells.

Authors:  P S Collis; B J O'Donnell; D J Barton; J A Rogers; J B Flanegan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Intracellular topology and epitope shielding of poliovirus 3A protein.

Authors:  Sunny S Choe; Karla Kirkegaard
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Identification of tolerated insertion sites in poliovirus non-structural proteins.

Authors:  Natalya L Teterina; Chris Lauber; Kenneth S Jensen; Eric A Levenson; Alexander E Gorbalenya; Ellie Ehrenfeld
Journal:  Virology       Date:  2010-10-23       Impact factor: 3.616

6.  Role of microtubules in extracellular release of poliovirus.

Authors:  Matthew P Taylor; Trever B Burgon; Karla Kirkegaard; William T Jackson
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

7.  Role of a viral membrane polypeptide in strand-specific initiation of poliovirus RNA synthesis.

Authors:  C Giachetti; B L Semler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Bypass suppression of small-plaque phenotypes by a mutation in poliovirus 2A that enhances apoptosis.

Authors:  Trever B Burgon; Jomaquai A Jenkins; Stephen B Deitz; Jeannie F Spagnolo; Karla Kirkegaard
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

Review 9.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

10.  A Redundant Mechanism of Recruitment Underlies the Remarkable Plasticity of the Requirement of Poliovirus Replication for the Cellular ArfGEF GBF1.

Authors:  Ekaterina G Viktorova; Samuel Gabaglio; Justyna M Meissner; Eunjoo Lee; Seyedehmahsa Moghimi; Elizabeth Sztul; George A Belov
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.